Latest filing published 31 Mar 2026 for CELLECTIS. Read the official filing
No signal scores available.
All filings by Stephan Reynier on record concern Cellectis, in the capacity of senior executive. Over a trading history stretching from 3 March 2025 to 24 May 2025, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 31 March 2026: a share grant, in Cellectis. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations